Buy Crypto Markets Spot FuturesGOLD Earn Event Center

The board of UAE hospital operator Burjeel Holdings has recommended a dividend of AED120 million ($33 million) for 2025. The company said its revenue grew by 10The board of UAE hospital operator Burjeel Holdings has recommended a dividend of AED120 million ($33 million) for 2025. The company said its revenue grew by 10

Burjeel board plans $33m dividend for 2025

Author: Agbi

Source: Agbi

2026/03/05 21:03

1 min read

For feedback or concerns regarding this content, please contact us at [email protected]

The board of UAE hospital operator Burjeel Holdings has recommended a dividend of AED120 million ($33 million) for 2025.

The company said its revenue grew by 10 percent last year to AED5.5 billion with patient visits exceeding 7 million, the company said in a release.

Net profit increased 40 percent to AED503 million and the net margin expanded to 9.2 percent, reflecting stronger operating leverage, disciplined control of non-operating costs and gains from asset optimisation initiatives, the release said.

Bloomberg reported last month that the company planned a debut dollar sukuk.

As of December 31, 2025, Burjeel operated 115 assets, supported by 1,784 beds and 1,776 physicians. Its portfolio of brands includes Burjeel, Medeor, LLH, Lifecare, PhysioTherabia, Alkalma and Tajmeel.

The company’s stock closed 4 percent lower at AED1.19 on the Abu Dhabi Securities Exchange on Thursday and is down 11 percent so far this year.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.